Background Persistence of antibodies to SARS-CoV-2 viral infection may depend on several
factors and may be related to the severity of disease or to the different symptoms. Methods …

Introduction The longevity of antibody levels against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major …

Background Understanding the longevity of antibodies against SARS-CoV-2 infection is of
utmost importance in predicting the further course of the pandemic and to plan vaccination …

Objectives Durability of the humoral immune response to SARS-CoV-2 has yet to be
defined. We longitudinally evaluated during a 12-month period the antibody responses to …

SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with
unprecedented strain on health care systems. To investigate the time course of the antibody …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic
recently. The prevalence and persistence of antibodies following a peak SARS-CoV-2 …

SARS-CoV-2 symptoms are non-specific and can range from asymptomatic presentation to
severe pneumonia. Asymptomatic subjects carrying SARS-CoV-2 often remain undiagnosed …

Objectives Dynamics of antibody responses following SARS-CoV-2 infection are
controversial in terms of immunity and persistence. We aimed to assess longitudinally the …

Background The role of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
neutralizing antibody response from natural infection and vaccination, and the potential …

Background: Assessing the humoral immune response to SARS-CoV-2 is crucial for
inferring protective immunity from reinfection and for assessing vaccine efficacy. Data …